BR9914898A - Processo para a preparação de um agente antiviral - Google Patents

Processo para a preparação de um agente antiviral

Info

Publication number
BR9914898A
BR9914898A BR9914898-6A BR9914898A BR9914898A BR 9914898 A BR9914898 A BR 9914898A BR 9914898 A BR9914898 A BR 9914898A BR 9914898 A BR9914898 A BR 9914898A
Authority
BR
Brazil
Prior art keywords
antiviral agent
preparation
formaldehyde
phenol
agent
Prior art date
Application number
BR9914898-6A
Other languages
English (en)
Inventor
Hans-Guenther Sonntag
Oliver Nolte
Hannelore Weiss
Hans-Erich Weiss
Original Assignee
Sonntag Hans Guenter
Oliver Nolte
Hannelore Weiss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sonntag Hans Guenter, Oliver Nolte, Hannelore Weiss filed Critical Sonntag Hans Guenter
Publication of BR9914898A publication Critical patent/BR9914898A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16061—Methods of inactivation or attenuation
    • C12N2740/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Patente de Invenção: <B>''PROCESSO PARA A PREPARAçãO DE UM AGENTE ANTIVIRAL''<D>. A presente invenção refere-se a um processo de preparação de um agente antiviral, em que o sangue contendo vírus e antígenos é aquecido a uma temperatura aproximadamente maior que 50°C, na presença de agentes de porteínas reticulados, preferencialmente formaldeído, p-formaldeído e/ou fenol ou derivados de fenol.
BR9914898-6A 1998-10-28 1999-10-09 Processo para a preparação de um agente antiviral BR9914898A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19849641 1998-10-28
PCT/EP1999/007588 WO2000024420A1 (de) 1998-10-28 1999-10-09 Verfahren zur herstellung eines antiviralen mittels

Publications (1)

Publication Number Publication Date
BR9914898A true BR9914898A (pt) 2001-07-17

Family

ID=7885889

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914898-6A BR9914898A (pt) 1998-10-28 1999-10-09 Processo para a preparação de um agente antiviral

Country Status (9)

Country Link
US (1) US20020001595A1 (pt)
EP (1) EP1124575B1 (pt)
JP (1) JP2002528422A (pt)
AT (1) ATE295179T1 (pt)
AU (1) AU6090899A (pt)
BR (1) BR9914898A (pt)
CA (1) CA2348840A1 (pt)
DE (2) DE19916085A1 (pt)
WO (1) WO2000024420A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19860438C1 (de) * 1998-12-28 2000-09-07 Sonntag Hans Guenther Verfahren zur Herstellung von Autovakzinen zur Behandlung von Chlamydiosen von Säugetieren und Menschen
DE10021433B4 (de) * 2000-05-03 2006-04-13 Sonntag, Hans-Günther, Prof. Dr. Dr. Verfahren zur Herstellung eines antiviralen Mittels
US9974847B2 (en) 2000-08-24 2018-05-22 Immunitor USA, Inc. Treatment and prevention of tuberculosis
US20030092145A1 (en) 2000-08-24 2003-05-15 Vic Jira Viral vaccine composition, process, and methods of use
JP2004317154A (ja) * 2003-04-11 2004-11-11 Mitsubishi Kagaku Iatron Inc 単核球抽出液の製造方法及び単核球抗原の分析方法
GB0326439D0 (en) * 2003-11-13 2003-12-17 Imp College Innovations Ltd Methods
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8802113B2 (en) * 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) * 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
WO2009097863A1 (en) * 2008-02-07 2009-08-13 Waseem Rochdy Elseesy Auto vaccination for hiv+ve patients, auto haemotherapy for aids disease
US9283266B2 (en) * 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
US20110150934A1 (en) * 2009-12-18 2011-06-23 University Of Notre Dame Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
US10881723B2 (en) 2016-01-15 2021-01-05 Km Biologics Co., Ltd. Vaccine containing immobilized virus particles
ES2853350A1 (es) * 2020-02-26 2021-09-15 Gonzalez Christian Konjevic Metodo para la elaboracion de vacunas terapeuticas mediante el calentamiento de suero sanguineo autologo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56108716A (en) * 1980-01-30 1981-08-28 Sanwa Kagaku Kenkyusho:Kk Antiviral agent containing different kind dead cell mixture as effective component
DD206842A1 (de) * 1982-01-11 1984-02-08 Bernd Olesch Verfahren zur herstellung eines haematologischen kontrollmaterials
JPH0761955B2 (ja) * 1988-04-28 1995-07-05 国立予防衛生研究所長 凍結乾燥ａ型肝炎ワクチン
IL99589A0 (en) * 1990-10-03 1992-08-18 Yeda Res & Dev T cell vaccination for prevention and treatment of allergy or graft rejection
GB9110808D0 (en) * 1991-05-17 1991-07-10 Retroscreen Ltd Aids vaccine and method for its production
GB9223035D0 (en) * 1992-11-03 1992-12-16 Kiessling Cooper Ann A Preservation of peripheral blood & semen in fixatives that inactivate human pathogens

Also Published As

Publication number Publication date
DE59912050D1 (de) 2005-06-16
AU6090899A (en) 2000-05-15
ATE295179T1 (de) 2005-05-15
EP1124575B1 (de) 2005-05-11
DE19916085A1 (de) 2000-05-04
EP1124575A1 (de) 2001-08-22
US20020001595A1 (en) 2002-01-03
WO2000024420A1 (de) 2000-05-04
JP2002528422A (ja) 2002-09-03
CA2348840A1 (en) 2000-05-04

Similar Documents

Publication Publication Date Title
BR9914898A (pt) Processo para a preparação de um agente antiviral
BR0014767A (pt) Fibras de sementes de plantas e uso
BR0206985A (pt) Anticorpos modificados e métodos de uso
BR9914638A (pt) Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo
NO20013701D0 (no) HER-2/neu-fusjonsproteiner
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
DE69029257D1 (de) Anordnung zur bestrahlung von laserstrahlen
BR9714164B1 (pt) combinação de herbicida-protetor; agente e processo para proteção de plantas; derivados de ácido 2-fluoracrìlico, seu emprego e processo para prepará-los.
PT1066269E (pt) Derivados de 1,3,5-triazina trissubstrituidos para o tratamento de infeccoes por hiv
BR9002717A (pt) Composicao,artigo esterilizado por radiacao e processo para esterilizacao de um artigo
BR0103736A (pt) Uso de uma composição que compreende pelo menos um composto metalo-orgânico e processo de tratamento das matérias queratìnicas
BR0012983B1 (pt) processo de tratamento por impregnaÇço de um material arquitetural, e, material arquitetural &#34;permeÁvel&#34;.
NO177526C (no) Fremgangsmåte for fremstilling av farmasöytisk aktive konjugater
BR0213595A (pt) Composição aquosa para tratamento dos cabelos e método para fornecer forma aos cabelos
DK103688D0 (da) Sammensaetninger til anvendelse ved permanent aendring af haarstruktur
BR0211922A (pt) Método para secagem de artigos de tecido contendo fluido lipofìlico, sistema de secagem dos referidos artigos, bem como artigo de tecido assim obtido
BR9006664A (pt) Processo para preparacao de tanino insoluvel,processo para tratamento de residuos usando tanino insoluvel,e processo de adsorcao que usa tanino
DE60007047T2 (de) Keramic-Polymer-Zusammensetzungen
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
EP0948967A3 (en) Treatment of viral disease in swine
BR9811325A (pt) Composição de revestimento, processo para curar a mesma, e, processo para preparação de um composto.
AR023199A1 (es) Solucion acuosa estable de em12, y procedimiento de preparacion de dicha solucion
ES2143569T3 (es) Piezas moldeadas de policarbonato mejoradas.
MX163461B (es) Procedimiento para preparar diazaoxaespirodecanos oligomeros,y su utilizacion como agentes fotoprotectores para polimeros
BR0112652A (pt) Processo para preparar um sal de um composto, composto, e, processos para preparar um composto e 4-aminofenilacetamida

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]